眼科 ›› 2025, Vol. 34 ›› Issue (1): 27-33.doi: 10.13281/j.cnki.issn.1004-4469.2025.01.005

• 论著 • 上一篇    下一篇

真性小眼球PRSS56基因突变与临床特征研究

陶靖1 郝洁2 沈人娟1 傅语潇2 李姣2 王序文2   

  1. 1首都医科大学附属北京同仁医院 北京同仁眼科中心 眼科学与视觉科学北京市重点实验室,北京100730; 2中国医学科学院/北京协和医学院医学信息研究所,北京100020
  • 收稿日期:2024-09-25 出版日期:2025-01-25 发布日期:2025-01-17
  • 通讯作者: Wang Xuwen, Email: wang.xuwen@imicams.ac.cn E-mail:wang.xuwen@imicams.ac.cn
  • 基金资助:
    国家自然科学基金(30700920,61906214)

PRSS56 gene mutations and clinical characteristics in Chinese patients with nanophthalmos#br#

Tao Jing1, Hao Jie2, Shen Renjuan1, Fu Yuxiao2, Li Jiao2, Wang Xuwen2   

  1. 1 Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University; Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing 100730, China; 2 Institute of Medical Information, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100020, China
  • Received:2024-09-25 Online:2025-01-25 Published:2025-01-17
  • Contact: Wang Xuwen, Email: wang.xuwen@imicams.ac.cn E-mail:wang.xuwen@imicams.ac.cn
  • Supported by:
    National Natural Science Fundation of China (30700920,61906214)

摘要: 目的 研究中国真性小眼球患者PRSS56基因突变的遗传和临床特征,揭示基因型与表型之间的相关性。设计 回顾性病例系列。研究对象 2003-2023年在北京同仁医院眼科就诊并随访的40个真性小眼球家系。方法 回顾对患者和家系成员进行的详细眼科检查资料。对40个家系中有血样的51例患者及42例家系成员采用全外显子组测序(WES)分析PRSS56基因编码区和相邻内含子区,并进行生物信息学分析和致病性预测。基因型与表型的发生率统计分析采用SPSS27.0和R 4.4.1软件进行。主要指标 眼部检查结果、突变基因型、闭角型青光眼(ACG)及葡萄膜渗漏综合征(UES)并发症的发生情况。结果 在这40个真性小眼球家系中,检测出15个与PRSS56基因突变相关的家系(其中先证者 15 例,患病家属 5例),检出率为37.50%(15/40)。共发现16种PRSS56基因突变,包括3种新突变[c.494dupG(p.Glu167Gly) 、c.340dupG(p.Ala115Gly) 、c.407C>T(p.Ala136Val)]和13种已报道的突变。其中c.1066dupC突变频率为53.33%(8/15),是本队列中最常见的突变。PRSS56基因突变的真性小眼球呈现视力低下、眼轴短、前房浅、视盘拥挤、视网膜血管扩张迂曲、黄斑区视网膜皱褶等临床特征。首诊年龄>40岁组的平均巩膜厚度更厚,平均中央前房深度更浅,发生ACG和UES的比例更高(P均<0.05)。c.1066dupC高频突变携带组呈现眼前节更短的趋势。结论 本研究阐述了中国真性小眼球PRSS56基因突变与临床特征及其相关性,扩展了PRSS56基因的突变谱,加深了真性小眼球基因型和表型关联的认识,为该病的精确诊疗和预后管理奠定了更加完善的理论基础。(眼科,2025, 34: 27-33)

关键词: 真性小眼球, PRSS56基因突变

Abstract: Objective To explore the genetic and clinical characteristics of PRSS56 gene mutations in Chinese patients with nanophthalmos and to reveal correlations between genotypes and phenotypes. Design Retrospective case series. Participants Forty unrelated Chinese families with nanophthalmos, diagnosed and followed up at Beijing Tongren Hospital from 2003 to 2023. Methods Comprehensive ophthalmic examinations were performed on the patients and their family members. Peripheral venous blood was collected from 51 patients and 42 family members with normal ocular phenotypes. DNA was extracted, and the coding region and adjacent intron regions of the PRSS56 gene were analyzed by whole-exome sequencing (WES), followed by bioinformatics analysis and pathogenicity prediction. Statistical analysis of genotypes and phenotypes was conducted using SPSS 27.0 and R 4.4.1 software. Main Outcome Measures Ophthalmic examination results, mutant genotypes, and the proportion of complications such as angle-closure glaucoma (ACG) and uveal effusion syndrome (UES). Results PRSS56 gene mutations were identified in 15 of 40 unrelated Chinese nanophthalmos families (15 probands and 5 affected family members ), with a detection rate of 37.50%. A total of 16 PRSS56 gene mutations were discovered, including 3 novel mutations [c.494dupG (p.Glu167Gly), c.340dupG (p.Ala115Gly), c.407C>T (p.Ala136Val)] and 13 previously reported mutations. Among these, the mutation frequency of c.1066dupC was 53.33% (8/15), making it the most common mutation in this cohort. Nanophthalmos patients with PRSS56 gene mutations exhibited typical clinical features of poor vision, short axial length, and shallow anterior chamber, accompanied by optic disc crowding, tortuous and dilated retinal vessels, and retinal folds in the macular area. Patients first diagnosed after the age of 40 years had a thicker average scleral thickness, a shallower average central anterior chamber depth, and higher proportion of ACG and UES( all P<0.05). The group carrying the high-frequency mutation of c.1066dupC showed a tendency of having a shorter anterior segment. Conclusion This study elucidates the PRSS56 gene mutations and clinical characteristics in Chinese patients with nanophthalmos and their correlations, expands the mutation spectrum of the PRSS56 gene, deepens the understanding of genotype-phenotype correlations in nanophthalmos, and lays a more comprehensive theoretical foundation for the accurate diagnosis, treatment, and prognostic management of this disease. (Ophthalmol CHN, 2025, 34: 27-33)

Key words: nanophthalmos, PRSS56 gene mutations